ZA932362B - Cloning expression and uses of a novel secreted protein F-spondin - Google Patents

Cloning expression and uses of a novel secreted protein F-spondin

Info

Publication number
ZA932362B
ZA932362B ZA932362A ZA932362A ZA932362B ZA 932362 B ZA932362 B ZA 932362B ZA 932362 A ZA932362 A ZA 932362A ZA 932362 A ZA932362 A ZA 932362A ZA 932362 B ZA932362 B ZA 932362B
Authority
ZA
South Africa
Prior art keywords
spondin
secreted protein
novel secreted
cloning expression
cloning
Prior art date
Application number
ZA932362A
Other languages
English (en)
Inventor
Thomas M Jessell
Avihu Klar
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Publication of ZA932362B publication Critical patent/ZA932362B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA932362A 1992-04-02 1993-04-01 Cloning expression and uses of a novel secreted protein F-spondin ZA932362B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/862,021 US5279966A (en) 1992-04-02 1992-04-02 Cloning, expression and uses of a novel secreted protein, F-spondin

Publications (1)

Publication Number Publication Date
ZA932362B true ZA932362B (en) 1994-06-15

Family

ID=25337422

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA932362A ZA932362B (en) 1992-04-02 1993-04-01 Cloning expression and uses of a novel secreted protein F-spondin

Country Status (8)

Country Link
US (2) US5279966A (ja)
EP (1) EP0670895A4 (ja)
JP (1) JPH07508402A (ja)
KR (1) KR950700990A (ja)
AU (1) AU677185B2 (ja)
CA (1) CA2133443A1 (ja)
WO (1) WO1993020196A1 (ja)
ZA (1) ZA932362B (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7831594A (en) * 1993-09-09 1995-03-27 Duke University A method of promoting cellular function
US5474921A (en) * 1993-10-15 1995-12-12 Merck & Co., Inc. Expression and purification of phosphoinositide-specific phospholipase C-γ
US5834029A (en) * 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
JPH10505750A (ja) * 1994-09-16 1998-06-09 ザ スクリップス リサーチ インスティテュート 粘着および軸索の成長を刺激するサイトタクチン誘導体並びにその製造および使用方法
US5654145A (en) * 1994-10-04 1997-08-05 La Jolla Cancer Research Foundation Trophinin and trophinin-assisting nucleic acids and methods of detection thereof
US5693779A (en) * 1994-11-08 1997-12-02 The United States Of America As Represented By The Department Of Health And Human Services Production and use of anti-dorsalizing morphogenetic protein
WO1997029189A1 (en) * 1996-02-12 1997-08-14 Human Genome Sciences, Inc. Human neuronal attachment factor-1
US5871969A (en) * 1996-02-12 1999-02-16 Human Genome Sciences, Inc. Nucleic acids encoding human neuronal attachment factor-1
WO1998045442A2 (en) * 1997-04-10 1998-10-15 Zymogenetics, Inc. Secreted f-spondin homologs
EP0986400A4 (en) * 1997-05-09 2002-10-09 Smithkline Beecham Corp INTEGRIN LIGAND, HUMAN MINDIN
CA2240607A1 (en) 1997-08-13 1999-02-13 Kyowa Hakko Kogyo Co., Ltd. Novel vascular smooth muscle cell growth factor
EP1152011A1 (en) * 1999-02-12 2001-11-07 Kyowa Hakko Kogyo Co., Ltd. Peptides inhibiting vascular endothelial cell migration
IL147271A0 (en) * 1999-07-02 2002-08-14 Genentech Inc Compounds that bind her2
AU7119400A (en) * 1999-09-10 2001-04-10 Millennium Pharmaceuticals, Inc. Single nucleotide polymorphisms in genes
US20030232056A1 (en) * 1999-09-10 2003-12-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6613515B1 (en) * 1999-09-10 2003-09-02 Corixa Corporation Ovarian tumor sequences and methods of use therefor
US6727063B1 (en) 1999-09-10 2004-04-27 Millennium Pharmaceuticals, Inc. Single nucleotide polymorphisms in genes
US20020061552A1 (en) * 1999-12-17 2002-05-23 Dong Yan Mammalian dishevelled-associated proteins
US20030194703A1 (en) * 2000-11-13 2003-10-16 Stacey Bolk Association of thrombospondin polymorphisms with vascular disease
US7655411B2 (en) * 2002-08-23 2010-02-02 W2 Holdings, Inc. Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
US20040209310A1 (en) * 2003-03-03 2004-10-21 Sudhof Thomas C. Ligands that bind to the amyloid-beta precursor peptide and related molecules and uses thereof
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
US20070107073A1 (en) * 2003-11-19 2007-05-10 Develogen Aktiengesellschaft Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
US20050112696A1 (en) * 2003-11-25 2005-05-26 The University Of Texas Southwestern Medical Center Compositions, methods and assays related to secretase cleavage specificity
EP3424950A1 (en) 2006-10-06 2019-01-09 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Prevention of tissue ischemia, related methods and compositions
WO2008069975A2 (en) * 2006-12-01 2008-06-12 New York University Methods of using f-spondin as a biomarker for cartilage degenerative conditions
US9056898B2 (en) * 2007-09-20 2015-06-16 Washington University Attenuated RNA virus and applications thereof

Also Published As

Publication number Publication date
CA2133443A1 (en) 1993-10-14
JPH07508402A (ja) 1995-09-21
WO1993020196A1 (en) 1993-10-14
KR950700990A (ko) 1995-02-20
US5750502A (en) 1998-05-12
EP0670895A1 (en) 1995-09-13
US5279966A (en) 1994-01-18
AU3945593A (en) 1993-11-08
EP0670895A4 (en) 1996-03-13
AU677185B2 (en) 1997-04-17

Similar Documents

Publication Publication Date Title
ZA932362B (en) Cloning expression and uses of a novel secreted protein F-spondin
AU4840293A (en) Cloning and expression of pur protein
HK1003503A1 (en) Aerosol formulations of peptides and proteins
ZA943612B (en) Inhibition of hair growth
ZA943611B (en) Inhibition of hair growth
IL108175A0 (en) Cloning and expression of xylanase B
HU9402361D0 (en) New makrolides and use of them
EP0702080A3 (en) Azeotropic compositions containing octamethyltrisiloxane and n-propoxypropanol
ZA899778B (en) Reduction of piperidine-dion-derivatives and intermediates
EP0724650A4 (en) SELECTION AND USE OF ANTIVIRAL PEPTIDES
IL106505A0 (en) Isolation and cloning of a protein with tyrosine-phosphatase activity
HUP9600227A2 (en) Use of amides of phenyl-cyclohexyl-carboxylic acids
AU5592294A (en) Induction of dwarfing and early flowering using group 3 lea proteins
IL98074A0 (en) Recombinant production of hirudins and novel hirudins
EP0726964A4 (en) INSULATION AND COMPOSITION OF NEW GLYCOSIDASES
AU123895S (en) Point of sale terminal
GB9221976D0 (en) Shaped articles of zirconia
AU1269897A (en) Cloning, expression and uses of a novel secreted protein, F-spondin
GB9408466D0 (en) Cloning and functional expression of neurotoxins
GB9314036D0 (en) Manufacture of flexible and hollow members
ZA946619B (en) Production of diffluoromethane
CA72908S (en) Modular point of sale terminal
ZA937383B (en) Novel composition and process of preparing same
LTIP1527A (en) Cloning and expression of microbial phytase
GB9323811D0 (en) A method of hair extension